Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Recommended measures for the assessment of cognitive and physical performance in older patients with dementia: a systematic review.

Bossers WJ, van der Woude LH, Boersma F, Scherder EJ, van Heuvelen MJ.

Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):589-609. doi: 10.1159/000345038. Epub 2012 Dec 8.

2.

Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.

Vigen CL, Mack WJ, Keefe RS, Sano M, Sultzer DL, Stroup TS, Dagerman KS, Hsiao JK, Lebowitz BD, Lyketsos CG, Tariot PN, Zheng L, Schneider LS.

Am J Psychiatry. 2011 Aug;168(8):831-9. doi: 10.1176/appi.ajp.2011.08121844. Epub 2011 May 15.

3.

Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study.

Zheng L, Mack WJ, Dagerman KS, Hsiao JK, Lebowitz BD, Lyketsos CG, Stroup TS, Sultzer DL, Tariot PN, Vigen C, Schneider LS.

Am J Psychiatry. 2009 May;166(5):583-90. doi: 10.1176/appi.ajp.2008.08081218. Epub 2009 Apr 15.

4.

Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.

Livingston G, Walker AE, Katona CL, Cooper C.

J Neurol Neurosurg Psychiatry. 2007 Jan;78(1):25-9. Epub 2006 Jun 26.

Supplemental Content

Support Center